Urology Search
Urology Urology
prostatitis
PROSTATITIS

Prostatitis is the inflammation of the prostate that may be caused by infection, chronic pelvic pain syndrome or asymptomatic prostate inflammation.

Prominent features are genitourinary, pelvic or rectal pain and lower urinary tract symptoms, eg urinary frequency, urgency, hesitancy, weak stream and straining on urination, dysuria, pain that increased with urination.

Prostatitis Signs and Symptoms

Introduction

  • A spectrum of disorders that affect men whose symptoms are referable to the lower urogenital tract & perineum

Etiology

  • Etiologic agents are the same for both acute bacterial prostatitis (ABP) & chronic bacterial prostatitis (CBP) & include E coli (most commonly isolated pathogen), Enterococcus sp, Klebsiella sp, Proteus sp, P aeruginosa, C trachomatis, U urealyticum, T vaginalis
    • Immune-deficient or human immunodeficiency virus (HIV) patients may have pathogens such as S typhi, M avium, M tuberculosis, Candida sp, C immitis, B dermatitidis, H capsulatum

Signs and Symptoms

  • Prominent features are genitourinary, pelvic or rectal pain & lower urinary tract symptoms, eg urinary frequency, urgency, hesitancy, weak stream & straining on urination, dysuria, pain that increased w/ urination
Editor's Recommendations
Most Read Articles
Carfilzomib-based triplet regimen a potential upfront treatment for high-risk MM
Pearl Toh, 2 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Extreme sleep duration may up mortality risk in individuals with T2D
Audrey Abella, 4 days ago
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
How to control asthma well: Experts’ perspectives
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Once-weekly insulin as good as once-daily dose?
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.